XML 25 R18.htm IDEA: XBRL DOCUMENT
v3.19.2

12. Stock-based Compensation | 9 Months Ended
--- | ---
Jun. 30, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock-based Compensation | Note 12: Stock-Based Compensation From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period. Stock Options The following table summarizes stock option activity for the twelve months ended September 30, 2018 and the nine months ended June 30, 2019:
|  |  |  |  | Weighted |  |  | Weighted |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Remaining |  |  |  |
|  | Shares |  |  | Price |  |  | Contractual Life |  |  | Intrinsic Value |
Outstanding at September 30, 2017 |  |  | 211,668 |  |  | $ | 13.19 |  |  |  | 3.47 |  |  | $ | 454,417 |
Granted |  |  | 20,000 |  |  |  | 32.24 |  |  |  | 9.02 |  |  |  |  |
Exercised |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at September 30, 2018 |  |  | 231,668 |  |  | $ | 14.84 |  |  |  | 3.04 |  |  | $ | 162,500 |
Exercisable at September 30, 2018 |  |  | 190,639 |  |  | $ | 11.89 |  |  |  | 2.08 |  |  | $ | 162,500 |
Outstanding at September 30, 2018 |  |  | 231,668 |  |  | $ | 14.84 |  |  |  | 3.04 |  |  | $ | 162,500 |
Granted |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | – |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | (31,250 | ) |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at June 30, 2019 |  |  | 200,418 |  |  | $ | 15.88 |  |  |  | 2.63 |  |  | $ | – |
Exercisable at June 30, 2019 |  |  | 169,820 |  |  | $ | 13.65 |  |  |  | 1.64 |  |  | $ | – |
The Company recognized compensation expense of $31,602 and $49,817 during the three months ended June 30, 2019 and 2018, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures. The Company recognized compensation expense of $109,803 and $447,970 during the nine months ended June 30, 2019 and 2018, respectively. At June 30, 2019, the Company has $177,002 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects to recognize as compensation expense through October of 2022. The exercise price for stock options outstanding and exercisable outstanding at June 30, 2019 is as follows:
Outstanding |  |  | Exercisable |
Number of |  |  | Exercise |  |  | Number of |  |  | Exercise |
Options |  |  | Price |  |  | Options |  |  | Price |
| 25,000 |  |  |  | 7.50 |  |  |  | 25,000 |  |  |  | 7.50 |
| 31,250 |  |  |  | 10.00 |  |  |  | 31,250 |  |  |  | 10.00 |
| 4,167 |  |  |  | 10.86 |  |  |  | 4,167 |  |  |  | 10.86 |
| 4,167 |  |  |  | 10.86 |  |  |  | 4,167 |  |  |  | 10.86 |
| 4,167 |  |  |  | 10.86 |  |  |  | 2,430 |  |  |  | 10.86 |
| 4,167 |  |  |  | 10.86 |  |  |  |  |  |  |  |  |
| 6,250 |  |  |  | 12.50 |  |  |  | 6,250 |  |  |  | 12.50 |
| 6,250 |  |  |  | 15.00 |  |  |  | 6,250 |  |  |  | 15.00 |
| 75,000 |  |  |  | 15.18 |  |  |  | 75,000 |  |  |  | 15.18 |
| 8,000 |  |  |  | 23.41 |  |  |  | 8,000 |  |  |  | 23.41 |
| 8,000 |  |  |  | 27.60 |  |  |  | 8,000 |  |  |  | 27.60 |
| 8,000 |  |  |  | 31.74 |  |  |  |  |  |  |  |  |
| 8,000 |  |  |  | 36.50 |  |  |  |  |  |  |  |  |
| 8,000 |  |  |  | 41.98 |  |  |  |  |  |  |  |  |
| 200,418 |  |  |  |  |  |  |  | 170,514 |  |  |  |  |
The following table summarizes information about the Company’s non-vested shares outstanding as of June 30, 2019 and September 30, 2018:
|  |  |  |  | Average |
|  | Number of |  |  | Grant-Date |
Non-vested Shares |  | Shares |  |  | Fair Value |
Non-vested at September 30, 2017 |  |  | 36,668 |  |  | $ | 17.70 |
Granted |  |  | 20,000 |  |  | $ | 10.14 |
Vested |  |  | (15,639 | ) |  | $ | 15.72 |
Non-vested at September 30, 2018 |  |  | 41,029 |  |  | $ | 12.88 |
Non-vested at September 30, 2018 |  |  | 41,029 |  |  | $ | 12.88 |
Granted |  |  | – |  |  | $ | – |
Vested |  |  | (11,125 | ) |  | $ | 13.88 |
Non-vested at June 30, 2019 |  |  | 29,904 |  |  | $ | 14.14 |
Options were granted during fiscal 2018, where the exercise price was less than the common stock price at the date of grant or where the exercise price was greater than the common stock price at the date of grant. There have been no options granted in fiscal 2019 through June 30, 2019. The assumptions used in calculating the fair value of stock options granted in fiscal 2018 use the Black-Scholes option pricing model for options granted were as follows:
Risk-free interest rate | 1.25%
Expected life of the options | 5 and 10 years
Expected volatility | 107%
Expected dividend yield | 0%

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration